EP2787345
Meðhöndlunarmöguleikar fyrir Fabry-sjúkdóm
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.5.2007EP published:
24.2.2016EP application number:
14168748.3
EP translation filed:
25.5.2016Grant published:
15.6.2016EPO information:
European Patent Register
Max expiry date:
15.5.2027Expiry date:
15.5.2026Next due date:
31.5.2026
Title:
TREATMENT OPTIONS FOR FABRY DISEASE
Timeline
Today
16.5.2007EP application
24.2.2016EP Publication
25.5.2016Translation submitted
15.6.2016Registration published
15.5.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
1 Cedar Brook Drive, 08512, Cranbury, NJ, US
Inventor
Name:
Lockhart, DavidAddress:
Cranbury, NJ, US
Name:
Castelli, JeffAddress:
Cranbury, NJ, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
801089 PDate:
16.5.2006Country:
US
Number:
853631 PDate:
23.10.2006Country:
US
Supplementary protection
SPC number:
SPC169
Classification
Categories:
G01N 33/53, G01N 33/567, G01N 33/573, A61K 31/435
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 12.4.2016
Expires: 15.5.2017
Payer: Árnason Faktor
Number: 11
Paid: 10.4.2017
Expires: 15.5.2018
Payer: Árnason Faktor
Number: 12
Paid: 9.4.2018
Expires: 15.5.2019
Payer: Árnason Faktor
Number: 13
Paid: 5.4.2019
Expires: 15.5.2020
Payer: Árnason Faktor
Number: 14
Paid: 7.4.2020
Expires: 15.5.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.4.2021
Expires: 15.5.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 5.4.2022
Expires: 15.5.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 12.4.2023
Expires: 15.5.2024
Payer: Árnason Faktor ehf.
Number: 18
Paid: 5.4.2024
Expires: 15.5.2025
Payer: Árnason Faktor ehf.
Number: 19
Paid: 6.5.2025
Expires: 15.5.2026
Payer: Árnason Faktor ehf.